Compositions and methods for treating peripheral arterial disease
The present disclosure provides compositions and methods for treating peripheral arterial disease in a subject by administering an exonucleotide pyrophosphatase phosphodiesterase-1 (ENPP1) agent or an exonucleotide pyrophosphatase phosphodiesterase-3 (ENPP3) agent. 本公开提供了通过施用外核苷酸焦磷酸酯酶磷酸二酯酶-1(ENPP1)药...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
07.07.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present disclosure provides compositions and methods for treating peripheral arterial disease in a subject by administering an exonucleotide pyrophosphatase phosphodiesterase-1 (ENPP1) agent or an exonucleotide pyrophosphatase phosphodiesterase-3 (ENPP3) agent.
本公开提供了通过施用外核苷酸焦磷酸酯酶磷酸二酯酶-1(ENPP1)药剂或外核苷酸焦磷酸酯酶磷酸二酯酶-3(ENPP3)治疗受试者的外周动脉疾病的组合物和方法。 |
---|---|
Bibliography: | Application Number: CN202180061245 |